18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children
β Scribed by YUEN, M; LIM, W; CHAN, A; WONG, D; SUM, S; LAI, C
- Book ID
- 120219447
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 108 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1542-3565
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A total of 318 children were prospectively randomized in group 1 with two 5-g doses of recombinant vaccine given at 0 and 1 month; in group 2 with three 5-g doses of recombinant vaccine given at 0, 1, and 6 months; or in group 3 with three doses of plasma-derived vaccine given at 0, 1, and 6 months.
In a prospective randomized trial, 318 children aged between 3 mo and 11 yr who were negative for all hepatitis B markers were randomized to receive two 5-pg doses of hepatitis B recombinant DNA yeast vaccine at 0 and 1 m o (group 11, three 5 -~g doses of hepatitis B recombinant DNA yeast vaccine at